Rare diseases
Investigational molecules
Locations
Back to Germany578 clinical trials in Ulm, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
GermanyA Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
GermanyA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyStudy of SAR442970 to treat moderate to severe ulcerative colitis in adults
GermanyStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
GermanyStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
GermanyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
GermanyStudy of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion
GermanyStudy of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on colorectal cancer, acute myeloid leukemia, and various types of lymphomas. Studies are evaluating novel combination therapies and targeted treatments for patients with specific genetic mutations.
Multiple trials investigating innovative treatment approaches for blood cancers and solid tumors.
Clinical research targeting multiple sclerosis, Alzheimer's disease, and amyotrophic lateral sclerosis. Studies are exploring new therapeutic agents and diagnostic tools.
Innovative approaches in neurodegenerative disease management and treatment.
Comprehensive studies on inflammatory bowel diseases, rheumatoid arthritis, and Sjögren's disease. Research focuses on novel biological therapies and long-term treatment options.
Advanced therapeutic approaches for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
